Loading organizations...
Loading organizations...
| Date | Company | Round | Lead Investor(s) | Co-Investor(s) |
|---|---|---|---|---|
| Apr 2, 2013 | Revance Therapeutics | $104.0M Other Equity / Series E | — | Bio*One Capital, Delphi Ventures, NovaQuest Capital Management, Pac-Link Ventures, Palo Alto Investors, Technology Partners, Vivo Ventures |
| Jun 10, 2011 | Revance Therapeutics | $45.0M Other Equity | Jonathan Tunnicliffe | CNF Investments, Essex Capital Corporation, Pac-Link Ventures, Palo Alto Investors, Technology Partners, Vivo Ventures |
| Jan 1, 2010 | Revance Therapeutics | $26.0M Series D | — | Vivo Capital, Bio*One Capital, Pac-Link Ventures, Palo Alto Investors, Technology Partners, Vivo Ventures |